A Phase 3, Multi-Center, Open-Label Study to Assess the Diagnostic Performance and Clinical Impact of 18F-DCFPyL PET/CT Imaging Results in Men With Suspected Recurrence of Prostate Cancer

Conditions

Prostate

Phase III

What is the purpose of this trial?

A Phase 3, Multi-Center, Open-Label Study to Assess the Diagnostic Performance and Clinical Impact of 18F-DCFPyL PET/CT Imaging Results in Men With Suspected Recurrence of Prostate Cancer

  • Ages
    18 years and older
  • Gender
    Male only
  • Trial with
    Progenics Pharmaceuticals
  • Start Date
    11/26/2018
  • End Date
    12/31/2019

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

Trial Image

For more information about this study, contact:

Svetlana Vassilieva

  • Last Updated
    01/03/2019
  • Study HIC
    #2000024006